| 英文别名： |
MometasoneFuroate;SCH-32088;MOMETASONE 17-FUROATE;NASONEX;(11-beta,16-alpha)-xy-16-methyl;pregna-1,4-diene-3,20-dione,9,21-dichloro-17-((2-furanylcarbonyl)oxy)-11-hydro;9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one furoate;(11BETA,16ALPHA)-9,21-DICHLORO-17-[(2-FURANYLCARBONYL)OXY]-11-HYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE;[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;Sch32088;: Mometasone furoate;9,21;(11β,16α)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione;Mometasone Furoate;Elocon;Asmanex;Mometasone fuorate;MOMETASONE FUROATE MONOHYDRATE;Danitin;Ecural;Asmanex Twisthaler;Flumeta;Nosorex;Rimelon;Elocone;04201GDN4R;Sch 32088;Elomet;DSSTox_CID_3333;DSSTox_RID_76981;DSSTox_GSI;9-Chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one furoate;Mometasone furoate;(11β,16α)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione (ACI);Elocom;LYR 210;Mometasone 17-(2-furoate);Monovo;Nasonex;Ovixan;Twisthaler;BDBM50148733;NSC-746171;LYR210;mometasone furoate;LAS 41002;PREGNA-1,4-DIENE-3,20-DIONE, 9,21-DICHLORO-17-((2-FURANYLCARBONYL)OXY)-11-HYDROXY-16-METHYL-, (11.BETA.,16.ALPHA.);Q1044248;NSC 760077;Mometasone furoate (USAN:USP:JAN);HY-13693;(11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione;WOFMFGQZHJDGCX-ZULDAHANSA-N;Sinuva;SR-01000841209;Mometasone furoate, United States Pharmacopeia (USP) Reference Standard;CAS-83919-23-7;UNII-04201GDN4R;BRD-K60640630-001-03-7;MOMETASONE FUROATE [ORANGE BOOK];AC-941;mometasone 17-furoate;(11beta,16alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate;Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-, (11beta,16alpha)-;(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate;DB14512;9,21-dichloro-11beta-hydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate;Prestwick3_000572;SPBio_002603;MFCD00866003;NASONEX 24HR ALLERGY;LYR-220 ACTIVE COMPONENT MOMETASONE FUROATE;s1987;AKOS015994732;Mometasone furoate, European Pharmacopoeia (EP) Reference Standard;Mometasone furoate (JAN/USP);CHEBI:47564;Childrens Nasonex;EN300-19766989;NSC-760077;SR-01000841209-2;Mometasone Furoate, Pharmaceutical Secondary Standard; Certified Reference Material;MOMETASONE FUROATE [JAN];NCGC00179578-03;Prestwick0_000572;NSC746171;M2354;MOMETASONE FUROATE [USAN];(9beta,10alpha,11alph... |
沪公网安备31011402010658号 
